FDA: Hypertension Tx Currently in Shortage

The Food and Drug Administration (FDA) announced that Bystolic (nebivolol; Forest Laboratories) 20mg is currently in shortage.

Bystolic 20mg tablets in 30- and 90-count bottles are currently unavailable and backordered due to a manufacturing delay based upon commercial stability data. The estimated duration of the backorder is 4–6 months. However, Bystolic 10mg tablets are available to cover the demand for the 20mg tablets.

RELATED: Beta-Blocker Pharmacokinetics Chart

Bystolic is a cardioselective beta-blocker indicated for the treatment of hypertension in adults ≥18 years of age. In addition to the 10mg tablets, it is also available as 2.5mg and 5mg tablets.

For more information call (888) 463-6332 or visit FDA.gov.